News Archives - Blogs & Articles

Discussing combination strategies, pre-clinical and translational immune-oncology developments at the 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress

September 7, 2020September 7, 2020 MarketsandMarkets Conferences

September 7th – The 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress to be held on 29th – 30th October 2020 (British Standard Time) would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress will gather 20+ sponsors, 30+ leading industry speakers and 200+ professional. The 2-day event…

Call for Abstracts Announced for MarketsandMarkets Gen-Next Probiotics and Microbiome Congress

January 17, 2020 MarketsandMarkets Conferences

January 10, 2020 – Witness the major breakthroughs of microbiome, probiotics and prebiotics research along with their applications pertaining to challenges like medicinal data interpretation, investment and regulatory hurdles faced by the practitioners at the MarketsandMarkets Gen-Next Probiotics and Microbiome Congress taking place on February 6-7, 2020 at Sheraton San Diego Hotel & Marina. We are delighted to announce the submission of abstracts from January 10. The call for abstracts presents an opportunity for academic and industry experts to be a part of the two-day congress and showcase their expertise…

Speaker Interview with Fabio D’Agostino for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

January 7, 2020 MarketsandMarkets Conferences

London, January 07 – MarketsandMarkets interviewed Fabio D’Agostino,Venture Partner, Claris Ventures regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Q. What is the most trending areas of cellular therapies currently? A. CART and NK cell Q. What are the recent developments and technological advancements? A. CART for solid tumors and NK CAR Q. What are the key take away points from your presentation? A. They are basically summarized in my bullet points. I will…

Speaker Interview with Karin Jennbacken for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

December 13, 2019December 16, 2019 MarketsandMarkets Conferences

London, December 13 – MarketsandMarkets interviewed Karin Jennbacken, Team Leader, Heart Failure in vitro team, AstraZeneca regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Dr Jennbacken’s team is responsible for target discovery and early development of therapeutics for treatment of patients with cardiovascular disease. Q. What is the most trending areas of cellular therapies currently? A. Cardiac therapies using pluripotent stem cells is where most of the researches are going on. Q. What are the…

Speaker Interview with Petter Björquist for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

December 13, 2019December 13, 2019 MarketsandMarkets Conferences

London, December 13 – MarketsandMarkets interviewed Petter Björquist, CEO, Verigraft regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Petter Björquist is a PhD in Biology/Biochemistry from Gothenburg University, 50 + publications in peer reviewed journals, several book chapters and patents. Q. What is the most trending areas of cellular therapies currently? A. I would say that is 1) CAR T-cell Therapy. This field has exploded, and started a new era in cancer treatment. 2) Genome…

Speaker Interview with Momchilo Vuyisich for MarketsandMarkets Gen-Next Probiotics and Microbiome Congress

December 12, 2019December 12, 2019 MarketsandMarkets Conferences

San Diego, December 12, 2019 – MarketsandMarkets recently interviewed Momchilo Vuyisich, Founder and Chief Science Officer, Viome, Inc regarding the MarketsandMarkets Gen-Next Probiotics and Microbiome Congress taking place on February 6-7, 2020 at Sheraton San Diego Hotel & Marina, San Diego. Q. What is the real role of probiotics strains, prebiotics and symbiotic in influencing a health? What are the essentials being missed out on? A. The field has focused on taxonomy and not functions of probiotics. We need to focus on probiotic colonization and expression of beneficial functions using…

Speaker Interview with Maya Ivanjesku for MarketsandMarkets Gen-Next Probiotics and Microbiome Congress

December 12, 2019December 12, 2019 MarketsandMarkets Conferences

San Diego, December 12, 2019 – MarketsandMarkets recently interviewed Maya Ivanjesku, Chief Scientific Officer, Dakota Biotech regarding the MarketsandMarkets Gen-Next Probiotics and Microbiome Congress taking place on February 6-7, 2020 at Sheraton San Diego Hotel & Marina, San Diego. Q. What is the real role of probiotics strains., prebiotics and symbiotic in influencing a health? What are the essentials being missed out on? A. Probiotics are the guardians of our health prebiotics is a necessary nutrient that will assure the viability of flora. Having good bacteria work together is necessary…

5th Annual Infection control, Sterilization and Decontamination congress announced with Speaker Line-up of Leading NHS Hospitals.

November 18, 2019November 18, 2019 MarketsandMarkets Conferences

MarketsandMarkets is organizing its 5th Annual Infection Control, Sterilization & Decontamination in Healthcare congress at Millennium Gloucester Hotel London Kensington on 19-20March 2020, which will focus on challenges associated with HAIs. With attendance of professionals from NHS hospitals, Research Institutes and Universities specializing in Infection Control, Decontamination and Sterilization, this two-day event will present case studies on implementation of infection prevention method and various technologies in hospitals. London, November 1 – MarketsandMarkets presents to you the 5th Annual Infection Control, Sterilization & Decontamination in Healthcare Congress to be held on…

Blood infections may be caused by bacteria in probiotics in ICU patients

November 14, 2019 MarketsandMarkets Conferences

It’s gotten normal for patients in the ICU to get probiotics, both children and adult. According to the study published in Nature Medicine, between 2009 and 2014, 1.1 % of patients suffered from bacteremia who received probiotics in the hospital’s ICU. The study also stated, the microorganisms living in probiotic formulations like yogurt can cause blood infections in few cases as indicated by a study which cautions the use of the product in the hospital’s ICU. 6 ICU cases of bacteremia was compared by the researchers with another 16 patients…

Speaker Interview with Elodie Baumfeld Andre 2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress

September 10, 2019 MarketsandMarkets Conferences

Boston, September 9, 2019 – MarketsandMarkets recently interviewed Elodie Baumfeld Andre, Senior Director, Epidemiology Strategy Lead, Worldwide Medical & Safety, Pfizer regarding 2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress taking place on October 24 – 25, 2019 at DoubleTree by Hilton Boston-Downtown . Elodie Baumfeld Andre is the Epidemiology Strategy Lead within the Worldwide Medical & Safety group at Pfizer. In this role, Elodie’s focus is on generating Real World Evidence (RWE) to support regulatory decision-making and driving continued innovation by implementing novel clinical designs and developing operating models. She is…